Sartorius Ag Unspadr Stock Current Ratio
| SRT4 Stock | EUR 33.40 0.60 1.76% |
SARTORIUS AG UNSPADR fundamentals help investors to digest information that contributes to SARTORIUS's financial success or failures. It also enables traders to predict the movement of SARTORIUS Stock. The fundamental analysis module provides a way to measure SARTORIUS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SARTORIUS stock.
SARTORIUS |
SARTORIUS AG UNSPADR Company Current Ratio Analysis
SARTORIUS's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current SARTORIUS Current Ratio | 1.25 X |
Most of SARTORIUS's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SARTORIUS AG UNSPADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, SARTORIUS AG UNSPADR has a Current Ratio of 1.25 times. This is 57.04% lower than that of the Healthcare sector and 64.29% lower than that of the Medical Instruments & Supplies industry. The current ratio for all Germany stocks is 42.13% higher than that of the company.
SARTORIUS Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SARTORIUS's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SARTORIUS could also be used in its relative valuation, which is a method of valuing SARTORIUS by comparing valuation metrics of similar companies.SARTORIUS is rated below average in current ratio category among its peers.
SARTORIUS Fundamentals
| Return On Equity | 0.34 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.27 % | |||
| Shares Outstanding | 342.08 M | |||
| Price To Earning | 29.20 X | |||
| Revenue | 4.04 B | |||
| Gross Profit | 1.84 B | |||
| EBITDA | 1.29 B | |||
| Net Income | 336.27 M | |||
| Cash And Equivalents | 446.8 M | |||
| Cash Per Share | 6.53 X | |||
| Total Debt | 2.12 B | |||
| Debt To Equity | 1.30 % | |||
| Current Ratio | 1.25 X | |||
| Book Value Per Share | 27.44 X | |||
| Cash Flow From Operations | 736.83 M | |||
| Earnings Per Share | 1.57 X | |||
| Number Of Employees | 15.94 K | |||
| Beta | 0.63 | |||
| Market Capitalization | 27.76 B | |||
| Z Score | 7.8 | |||
| Annual Yield | 0 % | |||
| Last Dividend Paid | 1.25 |
About SARTORIUS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SARTORIUS AG UNSPADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SARTORIUS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SARTORIUS AG UNSPADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in SARTORIUS Stock
SARTORIUS financial ratios help investors to determine whether SARTORIUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SARTORIUS with respect to the benefits of owning SARTORIUS security.